Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Profit After Tax (2016 - 2025)

Palisade Bio has reported Profit After Tax over the past 16 years, most recently at -$8.9 million for Q4 2025.

  • Quarterly Profit After Tax fell 166.12% to -$8.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.8 million through Dec 2025, down 16.23% year-over-year, with the annual reading at -$16.8 million for FY2025, 16.23% down from the prior year.
  • Profit After Tax was -$8.9 million for Q4 2025 at Palisade Bio, down from -$2.9 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $8.1 million in Q3 2021 and troughed at -$31.7 million in Q2 2021.
  • The 5-year median for Profit After Tax is -$3.5 million (2024), against an average of -$4.5 million.
  • The largest YoY upside for Profit After Tax was 538.8% in 2021 against a maximum downside of 1615.07% in 2021.
  • A 5-year view of Profit After Tax shows it stood at $8.1 million in 2021, then plummeted by 146.0% to -$3.7 million in 2022, then grew by 20.13% to -$3.0 million in 2023, then fell by 12.55% to -$3.3 million in 2024, then tumbled by 166.12% to -$8.9 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Profit After Tax are -$8.9 million (Q4 2025), -$2.9 million (Q3 2025), and -$2.8 million (Q2 2025).